Lytix Biopharma: Presentation of third quarter 2023 results, November 9
Oslo, 23 October 2023. Lytix Biopharma – Lytix Biopharma AS (“Lytix”) (Euronext Growth Oslo: LYTIX), a clinical stage immuno-oncology company, will release its third quarter 2023 results on Thursday, November 9. The results will be presented in a webcast with CEO Øystein Rekdal, CDO Graeme Currie and CFO Gjest Breistein at 2:30 pm CEST.The presentation and subsequent Q&A session will be held in English and may be viewed live by registering here: https://forms.office.com/e/N0xJzSx0Gg The presentation will be available at www.lytixbiopharma.com in the Investors section from 08:00 am CET